MENU
+Compare
NCNA
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$1.09
Change
+$0.03 (+2.83%)
Capitalization
4.28M

NCNA NuCana plc Forecast, Technical & Fundamental Analysis

a developer of novel anti-cancer medicines

Industry Biotechnology
NCNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for NCNA with price predictions
Feb 21, 2025

NCNA's RSI Indicator ascends from oversold territory

The RSI Indicator for NCNA moved out of oversold territory on February 14, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 38 similar instances when the indicator left oversold territory. In of the 38 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on February 20, 2025. You may want to consider a long position or call options on NCNA as a result. In of 103 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NCNA just turned positive on February 19, 2025. Looking at past instances where NCNA's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where NCNA advanced for three days, in of 209 cases, the price rose further within the following month. The odds of a continued upward trend are .

NCNA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NCNA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NCNA entered a downward trend on February 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.782) is normal, around the industry mean (12.496). P/E Ratio (0.000) is within average values for comparable stocks, (84.451). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). NCNA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (251.218).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NCNA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NCNA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
NCNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NCNA is expected to report earnings to fall 96.57% to 0 cents per share on May 15

NuCana plc NCNA Stock Earnings Reports
Q1'24
Est.
$0.00
Q4'23
Missed
by $0.03
Q3'23
Est.
$0.00
Q2'23
Est.
$0.00
Q1'23
Est.
$0.00
The last earnings report on March 20 showed earnings per share of -3 cents, missing the estimate of 0 cents. With 84.11K shares outstanding, the current market capitalization sits at 4.28M.
A.I. Advisor
published General Information

General Information

a developer of novel anti-cancer medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3 Lochside Way
Phone
+44 1313571111
Employees
28
Web
https://www.nucana.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH218.015.83
+2.75%
Clean Harbors
CRGO4.06-0.04
-0.98%
Freightos Limited
MTX69.97-1.13
-1.59%
Minerals Technologies
CGNT9.14-0.42
-4.39%
Cognyte Software Ltd
TRNR1.00-0.06
-5.66%
Interactive Strength Inc

NCNA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NCNA has been closely correlated with RNAC. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if NCNA jumps, then RNAC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NCNA
1D Price
Change %
NCNA100%
+2.83%
RNAC - NCNA
93%
Closely correlated
-1.89%
AGEN - NCNA
93%
Closely correlated
-3.77%
SNPX - NCNA
92%
Closely correlated
+1.06%
ALLR - NCNA
86%
Closely correlated
+1.44%
NRXP - NCNA
85%
Closely correlated
-6.94%
More

Groups containing NCNA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NCNA
1D Price
Change %
NCNA100%
+2.83%
NCNA
(7 stocks)
33%
Loosely correlated
-1.58%